Overview of Dr. Fasano
Dr. Julie Fasano is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including The Mount Sinai Hospital and Memorial Sloan-Kettering Cancer Center. She received her medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 15 years. Dr. Fasano accepts several types of health insurance, listed below. She is one of 440 doctors at Memorial Sloan-Kettering Cancer Center and one of 188 doctors at The Mount Sinai Hospital who specialize in Oncology. She has 5 publications and over 150 citings.
Office
1 Gustave L Levy Pl
New York, NY 10029Fax+1 212-731-5210- Is this information wrong?
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2005 - 2008- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2007
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2005 - 2006
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2002 - 2005
Albert Einstein College of MedicineClass of 2002
Certifications & Licensure
NY State Medical License 2005 - 2024- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Discrepancies in estradiol levels in a premenopausal woman receiving abemaciclib despite ovarian function suppression and bilateral salpingo-oophorectomy.Alaina J Kessler, Rima Patel, Emily Jane Gallagher, Theresa Shao, Julie Fasano> ;Current Problems in Cancer. Case Reports. 2023 Mar 1
- 55 citationsPhase II Study of Paclitaxel Given Once per Week Along With Trastuzumab and Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Br...Chau T. Dang, Neil M. Iyengar, FM Datko, Gabriella D'Andrea, Maria Theodoulou, Maura N. Dickler, Shari Goldfarb, Diana Lake, Julie Fasano, Monica Fornier, Theresa Gile...> ;Journal of Clinical Oncology. 2015 Feb 10
- 79 citationsA phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer.Komal Jhaveri, Sarat Chandarlapaty, Diana Lake, Teresa Gilewski, Mark E. Robson, Shari Goldfarb, Pamela Drullinsky, Steven Sugarman, Carolyn Wasserheit-Leiblich, Julie...> ;Clinical Breast Cancer. 2014 Jun 1
- Join now to see all
Press Mentions
Drug Helps Fight Breast Tumors Tied to 'Cancer Genes'June 4th, 2017- 7 Questions to Ask Your Doctor if You’re Diagnosed with Metastatic Breast CancerOctober 26th, 2020
Hospital Affiliations
The Mount Sinai HospitalNew York, New York
Memorial Sloan-Kettering Cancer CenterNew York, New York
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Anthem Blue Access PPO
Anthem Blue Preferred HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPO
First Health PPOGHI PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
Sagamore Health Plus
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
